Your browser doesn't support javascript.
loading
Antibody titers and neutralizing activity in cases of COVID-19 after a single dose of vaccination.
Okumura, Nobumasa; Saito, Sho; Takamatsu, Yuki; Takeuchi, Junko S; Asai, Yusuke; Sanada, Mio; Iwamoto, Noriko; Maeda, Kenji; Mitsuya, Hiroaki; Ohmagari, Norio.
Affiliation
  • Okumura N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Saito S; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: ssaito@hosp.ncgm.go.jp.
  • Takamatsu Y; Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute, Tokyo, Japan.
  • Takeuchi JS; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Asai Y; AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Sanada M; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Iwamoto N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Maeda K; Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute, Tokyo, Japan.
  • Mitsuya H; Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute, Tokyo, Japan.
  • Ohmagari N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan; AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.
J Infect Chemother ; 28(12): 1704-1706, 2022 Dec.
Article de En | MEDLINE | ID: mdl-36067912
ABSTRACT
Vaccines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have shown high efficacy in preventing the onset of disease. However, the immune response to infection immediately after the first vaccination remains unknown. We examined the anti-SARS-CoV-2-binding-antibody titers and neutralizing activity in patients who developed coronavirus disease 2019 after the first vaccination. The amount of anti-SARS-CoV-2-binding antibodies and neutralizing activity drastically increased from the first to the second collection. Our results may provide important data on the course of immune response following vaccination.
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: COVID-19 Limites: Humans Langue: En Journal: J Infect Chemother Sujet du journal: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Année: 2022 Type de document: Article Pays d'affiliation: Japon Pays de publication: HOLANDA / HOLLAND / NETHERLANDS / NL / PAISES BAJOS / THE NETHERLANDS
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: COVID-19 Limites: Humans Langue: En Journal: J Infect Chemother Sujet du journal: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Année: 2022 Type de document: Article Pays d'affiliation: Japon Pays de publication: HOLANDA / HOLLAND / NETHERLANDS / NL / PAISES BAJOS / THE NETHERLANDS